The race to discover, develop, and market new therapeutics is fiercely competitive. This makes building an innovative functional genomics technology platform that can be integrated with the downstream ...

As stated in one of the chapters of this book, “genomics does not end when all base pairs of DNA have been sequenced”. Large-scale sequencing projects have triggered a giant step for biological ...

This activity was supported by the National Science Foundation under Award Number 1927620. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily ...

Unravel molecular mysteries in bat wing development / Collaborate with renowned experts / Shape the future of evolutionary biology. Apply now to lead transformative research in ...

Suggested Citation: "6 Predicting Current and Future Sources of Variation in Quantitative Traits." National Academies of Sciences, Engineering, and Medicine. 2020. Next Steps for Functional Genomics: ...

Are you attending the ABRF Annual Meeting 2026? Here are the breakout sessions and workshops you won’t want to miss.

Published as an arXiv preprint, the paper details how unsupervised and self-supervised AI models are matching or surpassing ...

A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...

Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.

Researchers screened more than 220,000 single-letter DNA changes, identifying thousands that regulate gene activity in brain, ...

EPFL The Board of the Swiss Federal Institutes of Technology has announced the appointment of professors at EPFL.New appointments at EPFL © ...

Autoimmune diseases are sweeping the globe. Around one in 20 Australians has an autoimmune diagnosis, though this may be underestimated. Globally, their prevalence is rising by about 12.5 per cent ...